A multicentric randomized phase II clinical trial evaluating high-dose thiotepa as adjuvant treatment to standard chemotherapy in patients with resectable relapsed osteosarcoma.
暂无分享,去创建一个
J. Blay | L. Brugières | D. Pérol | M. Brahmi | N. Corradini | N. Gaspar | J. Gentet | P. Marec-Berard | M. Tabone | C. Schmitt | C. Dalban | H. Pacquement | S. Metzger | M. Castex | C. Lervat